Further research revealed that one of these drugs, DDL-920 – developed at UCLA, led to the complete recovery of movement control – something many stroke patients never regain.

In many ways, 2024 was a year of consolidation at the top of the pharma industry rankings. Johnson & Johnson, having ascended to the top spot in 2023 held on to that position in 2024, adding more ...